8th NovAliX Conference

Developing the Synergy between Biophysics and Medicinal Chemistry to Deliver Better Drugs

Biophysics in Drug Discovery 2022 | European Edition

 Munich, Germany    May 9-11, 2022

Committee


Conference Chairman

Dr Jean-Paul RENAUD

Urania Therapeutics, Ostwald, France

Scientific Committee

Members

Dr Chun-wa CHUNG

GlaxoSmithKline, Stevenage, United Kingdom

Prof. Alessio CIULLI

University of Dundee, Dundee, United Kingdom

Prof. Helena DANIELSON

Uppsala University, Uppsala, Sweden

Dr Matthias FRECH

Merck, Darmstadt, Germany

Dr Stefan GESCHWINDNER

AstraZeneca, Mölndal, Sweden

Dr Sylwia HUBER

F. Hoffmann-La Roche, Basel, Switzerland

Dr Sandra JACOB

Novartis Institutes for Biomedical Research, Basel, Switzerland

Dr Herbert NAR

Boehringer Ingelheim, Biberach, Germany

Dr Jean-Paul RENAUD

Urania Therapeutics, Ostwald, France

Dr Stacey SOUTHALL

Sosei Heptares, Cambridge, United Kingdom